Table 3

Univariate and multivariate analyses of disease-free survival in patients with hormone receptor-positive/HER2-negative primary breast cancer
Univariate Multivariate
Total (n=142) Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Ki67-p53 Low Ki67 LI and Negative p53 88 1 1
High Ki67 LI and/or Positive p53 54 9.3 3.5-24.5 < 0.0001 11.6 4.2-32.3 < 0.0001
FOXA1 Low 20 1
High 119 1.4 0.51-3.6 0.54
GATA3 Negative 30 1
Positive 112 1.5 0.65-3.5 0.34
Basal phenotype marker Negative 9 1
(CK5/6, CK14, EGFR) Positive 133 1.0 0.24-4.3 0.98
P-cadherin Low 90 1
High 52 1.3 0.59-2.8 0.52
Tumor size <5.0 cm 17 1 1
≧5.0 cm 122 4.9 2.1-11.4 0.0003 5.7 2.3-14.1 0.0002
Lymph-node metastasis (−) 80 1
(+) 59 3.8 1.6-8.8 0.0020
Nuclear grade 1, 2 111 1
3 31 4.2 1.9-9.0 0.0002
Chemotherapy No 93 1 1
Yes 49 2.6 1.2-5.7 0.014 3.5 1.5-7.9 0.0028

Abbreviation: 95%CI 95% confidence interval, LI labeling index.

Kobayashi et al.

Kobayashi et al. BMC Clinical Pathology 2013 13:5   doi:10.1186/1472-6890-13-5

Open Data